Found: 45
Select item for more details and to access through your institution.
Editorial: Recent advancements in mycobacterial diseases research.
- Published in:
- Frontiers in Microbiology, 2024, p. 1, doi. 10.3389/fmicb.2024.1504449
- By:
- Publication type:
- Article
Bacterial load slopes represent biomarkers of tuberculosis therapy success, failure, and relapse.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02184-0
- By:
- Publication type:
- Article
Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 9, p. 1464, doi. 10.1093/infdis/jit352
- By:
- Publication type:
- Article
Reply to Alffenaar.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 12, p. 1951, doi. 10.1093/infdis/jir658
- By:
- Publication type:
- Article
Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Machine learning reveals that Mycobacterium tuberculosis genotypes and anatomic disease site impacts drug resistance and disease transmission among patients with proven extra-pulmonary tuberculosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relationship Between Drug Concentration in Tuberculosis Lesions, Epithelial Lining Fluid, and Clinical Outcomes.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. e3374, doi. 10.1093/cid/ciaa1271
- By:
- Publication type:
- Article
Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S317, doi. 10.1093/cid/ciy609
- By:
- Publication type:
- Article
Transformation Morphisms and Time-to-Extinction Analysis That Map Therapy Duration From Preclinical Models to Patients With Tuberculosis: Translating From Apples to Oranges.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S349, doi. 10.1093/cid/ciy623
- By:
- Publication type:
- Article
Artificial intelligence–derived 3-Way Concentration-dependent Antagonism of Gatifloxacin, Pyrazinamide, and Rifampicin During Treatment of Pulmonary Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S284, doi. 10.1093/cid/ciy610
- By:
- Publication type:
- Article
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S293, doi. 10.1093/cid/ciy611
- By:
- Publication type:
- Article
Gatifloxacin Pharmacokinetics/Pharmacodynamics–based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, p. S274, doi. 10.1093/cid/ciy618
- By:
- Publication type:
- Article
Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis Programs.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 11, p. 1743, doi. 10.1093/cid/ciy346
- By:
- Publication type:
- Article
Individualizing Tuberculosis (TB) Treatment: Are TB Programs in High Burden Settings Ready for Prime Time Therapeutic Drug Monitoring?
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 10, p. 1350, doi. 10.1093/cid/cix158
- By:
- Publication type:
- Article
Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, p. S80, doi. 10.1093/cid/ciw482
- By:
- Publication type:
- Article
A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, p. S95, doi. 10.1093/cid/ciw474
- By:
- Publication type:
- Article
Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, p. S88, doi. 10.1093/cid/ciw473
- By:
- Publication type:
- Article
A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, p. S75, doi. 10.1093/cid/ciw472
- By:
- Publication type:
- Article
Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, p. S63, doi. 10.1093/cid/ciw471
- By:
- Publication type:
- Article
Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S18, doi. 10.1093/cid/civ426
- By:
- Publication type:
- Article
Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S10, doi. 10.1093/cid/civ425
- By:
- Publication type:
- Article
Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S25, doi. 10.1093/cid/civ427
- By:
- Publication type:
- Article
Reply to Moonan and Weis, Seaworth et al, and Nunn and Phillips.
- Published in:
- 2013
- By:
- Publication type:
- Letter
A Meta-Analysis of Self-Administered vs Directly Observed Therapy Effect on Microbiologic Failure, Relapse, and Acquired Drug Resistance in Tuberculosis Patients.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 1, p. 21, doi. 10.1093/cid/cit167
- By:
- Publication type:
- Article
Drug Concentration Monitoring in Mycobacterium avium Lung Disease: Problems with Methods and Conclusions.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2013, v. 187, n. 5, p. 554, doi. 10.1164/ajrccm.187.5.554
- By:
- Publication type:
- Article
Measuring health-related quality of life in tuberculosis: a systemic review - Response.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Comparative Effectiveness of Methotrexate versus Methylprednisolone in Treatment Naïve Pulmonary Sarcoidosis Patients.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 8, p. 1401, doi. 10.3390/diagnostics11081401
- By:
- Publication type:
- Article
Pulmonary impairment after tuberculosis and its contribution to TB burden.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Minocycline Immunomodulates via Sonic Hedgehog Signaling and Apoptosis and Has Direct Potency Against Drug-Resistant Tuberculosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Urine colorimetry to detect Low rifampin exposure during tuberculosis therapy: a proof-of-concept study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Therapy duration and long-term outcomes in extra-pulmonary tuberculosis.
- Published in:
- BMC Infectious Diseases, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2334-14-115
- By:
- Publication type:
- Article
Therapy duration and long-term outcomes in extra-pulmonary tuberculosis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 4, p. 953, doi. 10.1093/jac/dkad029
- By:
- Publication type:
- Article
Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The discovery of ceftazidime/avibactam as an anti-Mycobacterium avium agent.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Linezolid as treatment for pulmonary Mycobacterium avium disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comment on: Clinical significance of 2 h plasma concentrations of first-line anti-tuberculosis drugs: a prospective observational study.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. 2, p. 169, doi. 10.1093/cid/cis353
- By:
- Publication type:
- Article